Skip to main content
OpenTrials
Completed

NCT Number: NCT06603909

Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management

You have completed the current stage of cancer treatment, after which you need to check regularly and pay attention to nutrition. So we started this study to see if AI could help with nutrition management. Main options: Option 1: Use AI to assist nutrition management; Option 2: Contact the nutritionist team of the hospital for nutrition management according to your own situation. Option 3: Do not adopt the first two management methods. Special Statement: Please choose; Cancer screening data is used for statistical analysis, but does not reveal any personal privacy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer, Carcinoma Artificial Intelligence (AI) Carcinoma Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Nutrition

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

First Affiliated Hospital of Zhengzhou University

Zhengzhou, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Malignant tumor patient

Exclusion criteria

  • no

Treatment and study plan

group 1: Use AI to assist nutrition management

Other

group1：AI-assisted nutrition management. group 2：Traditional nutrition management（through the hospital dietitian）.group 3:control.

group 2：Traditional nutrition management（through the hospital dietitian）

Other

group 2：Traditional nutrition management（through the hospital dietitian）

Primary outcomes

  1. Survival Rate

    Time frame: three years after treatment

    Survival Rate

  2. Local Recurrence Rate

    Time frame: three years after treatment

    Local Recurrence Rate

Secondary outcomes

  1. DNA positive rate of Epstein-Barr(EB) virus

    Time frame: three years after treatment

    DNA positive rate of Epstein-Barr(EB) virus

  2. Body mass index

    Time frame: three years after treatment

    Data was obtained through the intelligent body fat device

Sponsors and collaborators

Lead sponsor

Changsha Medical University

Other

Registry information

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.